文献速递衰弱、肌少症与跌倒认知障碍与谵妄

肌少症变化与痴呆风险:英国老龄化纵向研究10年随访证据

Change in sarcopenia and the risk of dementia: evidence from the English Longitudinal Study of Ageing with a 10-year follow-up.
PubMed 文献 · J Gerontol A Biol Sci Med Sci · 2026-01-01

基于英国老龄化纵向研究(2004-2019)3610名参与者,中位随访9.83年期间296人发生痴呆。相比稳定健壮者,从健壮进展为可能肌少症/肌少症者痴呆风险升高(HR=1.49,95%CI=1.05-2.10);而肌少症改善者未见痴呆风险降低(HR=0.79,95%CI=0.51-1.52)。累积体力活动水平部分中介了肌少症进展与痴呆风险的关联(自然间接效应HR=1.06,95%CI=1.01-1.13,中介比例15.4%)。

要点

  • 健壮进展为可能肌少症/肌少症者痴呆风险升高(HR=1.49)。
  • 肌少症改善未见痴呆风险降低(HR=0.79,无统计学意义)。
  • 累积体力活动部分中介肌少症进展与痴呆关联,中介比例15.4%。

核心结论

  • 肌少症的持续进展与痴呆风险升高相关,而肌少症改善未显示痴呆风险降低。
  • 累积体力活动水平部分中介了肌少症进展与痴呆风险的关联。

研究设计与样本

  • 数据来自英国老龄化纵向研究(ELSA,2004-2019),共纳入3610名参与者。
  • 肌少症状态依据EWGSOP2标准评估为健壮、可能肌少症和肌少症。
  • 采用Kaplan-Meier累积风险曲线、Cox比例风险模型和因果中介分析。

主要发现

  • 中位随访9.83年期间,296名参与者发生痴呆。
  • 相比稳定健壮者,从健壮进展为可能肌少症/肌少症者痴呆风险升高(HR=1.49,95%CI=1.05-2.10)。
  • 相比稳定肌少症者,从肌少症改善为可能肌少症/健壮者痴呆风险无显著降低(HR=0.79,95%CI=0.51-1.52)。
  • 累积体力活动水平中介肌少症进展与痴呆风险的关联,自然间接效应HR=1.06(95%CI=1.01-1.13),中介比例15.4%。

临床怎么用

  • 对老年患者应动态评估肌少症状态变化,进展性肌少症提示痴呆风险升高。
  • 促进累积体力活动可能部分降低肌少症进展相关的痴呆风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The study aimed to investigate the association between changes in sarcopenia and the risk of dementia, and whether cumulative levels of physical activity (PA) mediate the association of changes in sarcopenia with dementia. METHODS: Our data are from the English Longitudinal Study of Aging (2004-2019). Robust, probable sarcopenia and sarcopenia were assessed according to European Working Group of Sarcopenia in Older People (EWGSOP2) criteria. Kaplan-Meier cumulative risk curves were used to explore the association between changes in sarcopenia and the risk of dementia. Cox proportional hazard models were used to calculate the hazard ratios (HR) and 95% confidence intervals (95% CI). Causal mediation analysis was used to assess the mediating effects of cumulative levels of PA. RESULTS: A total of 3610 participants were included in the analysis. At a median follow-up time of 9.83 years, 296 participants developed dementia. Compared with participants with stable robust, participants with robust to probable sarcopenia/sarcopenia had an increased risk of dementia (HR = 1.49, 95% CI = 1.05-2.10); conversely, compared with participants with stable sarcopenia, participants with sarcopenia to probable sarcopenia/robust did not have a reduced risk of dementia (HR = 0.79, 95% CI = 0.51-1.52). The cumulative levels of PA mediate the association with robust to probable sarcopenia/sarcopenia and the risk of dementia with a natural indirect effect HR (95% CI) of 1.06 (1.01-1.13), proportion mediated = 15.4%. CONCLUSIONS: Different changes in sarcopenia were associated with different dementia risks, with continued progression of sarcopenia, increased dementia risk, and cumulative levels of PA mediated the association between the progression of sarcopenia and the risk of dementia.

来源:J Gerontol A Biol Sci Med Sci,查看原文。版权归原作者所有。

引用

  1. Zhong X, Huang Z, Huang B, et al. Change in sarcopenia and the risk of dementia: evidence from the English Longitudinal Study of Ageing with a 10-year follow-up. J Gerontol A Biol Sci Med Sci. 2026. PMID: 41485084. doi:10.1093/gerona/glaf290

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。